Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016;5(4):318-324.
doi: 10.1007/s13669-016-0183-x. Epub 2016 Nov 4.

Radiofrequency Ablation of Uterine Fibroids: a Review

Affiliations
Review

Radiofrequency Ablation of Uterine Fibroids: a Review

Bruce B Lee et al. Curr Obstet Gynecol Rep. 2016.

Abstract

Laparoscopic, ultrasound-guided radiofrequency ablation (RFA) is a new, FDA-cleared uterine sparing, outpatient procedure for uterine fibroids. The procedure utilizes recent technological advancements in instrumentation and imaging, allowing surgeons to treat numerous fibroids of varying size and location in a minimally invasive fashion. Early and mid-term data from multi-center clinical trials have demonstrated safety and efficacy, with resolution or improvement of symptoms and significant volume reduction. Re-intervention rates for fibroid symptoms have been low. The procedure is well tolerated with a typically uneventful and rapid recovery requiring NSAIDs only for postoperative pain. While post RFA pregnancy data are limited, the results are promising.

Keywords: Laparoscopy; Minimally invasive surgery; Radiofrequency ablation; Uterine fibroids.

PubMed Disclaimer

Conflict of interest statement

Bruce B. Lee is a shareholder in and consultant to Halt Medical, Inc., but did not receive financial support or assistance of any kind in the production of this manuscript. Steve P. Yu declares no conflicts of interest. Human and Animal Rights and Informed Consent All studies by Bruce B. Lee, MD involving animal and/or human subjects were performed after approval by the appropriate institutional review boards. When required, written informed consent was obtained from all participants.

Figures

Fig. 1
Fig. 1
Acessa System consisting of deployable multi-electrode array and RFA generator

Similar articles

Cited by

References

    1. Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188:100–107. doi: 10.1067/mob.2003.99. - DOI - PubMed
    1. Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012;206(211):e1–e9. - PMC - PubMed
    1. Hartmann KE, Birnbaum H, Ben-Hamadi R, Wu EQ, Farrell MH, Spalding J, et al. Annual costs associated with diagnosis of uterine leiomyomata. Obstetrics and Gynecol. 2012;108:930–937. doi: 10.1097/01.AOG.0000234651.41000.58. - DOI - PubMed
    1. Millennium Research Group, Inc. U.S. markets for gynecological devices 2011. 2010.
    1. D’Arsonval MA. Action physiologique des courants alternatifs. C R Soc Biol. 1891;43:283–286.